Market Research Logo

Angola Pharmaceuticals & Healthcare Q4 2018

Angola Pharmaceuticals & Healthcare Q4 2018

Key View:

The Angolan economy is set to recover from a prolonged downturn which has inhibited the government’s abilitydevelop a robust system for buying and distributing medicines or training doctors and nurses, weakening the pharmaceutical andhealthcare sectors. Angola’s new President, João Lourenço, has pledged to combat corruption, attract foreign investment andimprove healthcare services. However, we continue to view Angola as one of the least attractive markets multinational drugmakersin the region given its small size, low per capita spending and weak regulatory environment.

Key View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Industry Risk/Reward Index
Sub-Saharan Africa Innovative Pharmaceuticals Risk/Reward Index
Angola Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Nova Angomédica
Angola Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report